Font Size

Myeloma (cont.)

Myeloma Treatment

Patient Comments

Primary health care doctors will usually refer people with myeloma to a subspecialist usually called a hematologist or hematologist-oncologist.

  • Although medical treatments are fairly standardized, different doctors have different philosophies and practices in caring for their patients.
  • A person may want to consult with more than one specialist before selecting the hematologist-oncologist.
  • Family members, friends, and health care professionals are good resources to get referrals. Many communities, medical societies, and cancer centers offer telephone or Internet referral services.

During a consultation with a hematologist-oncologist, the person will have an opportunity to ask questions and to discuss the treatments available.

  • The doctor will present each type of treatment, give the pros and cons, and make recommendations based on published treatment guidelines and the doctor's experience.
  • Treatment for myeloma depends on the stage. Factors such as age, overall health, and recurrence of myeloma are included in the treatment decision-making process.
  • The decision of which treatment to pursue is made between the person's hematologist-oncologist (with input from other members of the care team) and family members, but the decision ultimately rests with the patient.
  • For optimal treatment results, a person should be certain to understand exactly what will be done and why, and what to expect from the treatments that have been decided upon.

Like all cancers, myeloma is most likely manageable when it is diagnosed early and treated promptly.

  • A treatment plan is individualized for a specific situation.
  • The first decision to be made is whether or not to offer the patient a stem cell transplant at any point in the future. This influences the types of medications to be prescribed for treatment at the outset.
  • The most widely used therapies are various types of chemotherapy, immune modulating or immunomodulatory drugs, cortisone derivatives such as prednisone or dexamethasone (corticosteroids), and/or radiation therapy.
  • Newer medications that are active against myeloma may be offered, either as single therapy or together with chemotherapy.
  • Supportive care is given to treat complications and symptoms. Some potential supportive care medications include growth factors for anemia and medications to treat bone disease.
  • High dose chemotherapy followed by a stem cell infusion - called a stem cell transplant is often offered as a best way to control multiple myeloma for as long as possible. It is often offered after completion of initial, or induction, treatment.
Medically Reviewed by a Doctor on 4/2/2015
Medical Author:
Medical Editor:
Medical Editor:
Medical Reviewer:

Must Read Articles Related to Myeloma

Bone Marrow Biopsy
Bone Marrow Biopsy A bone marrow biopsy is performed for any of the following reasons:
  • to evaluate bone marrow function or to determine the cause of some infections; /...
learn more >>
18 Cancer Symptoms
Cancer Symptoms Most symptoms and signs of cancer may also be explained by harmless conditions, so it's important to limit one's risk factors and undergo appropriate cancer scr...learn more >>
Cancer: What You Need to Know
Cancer: What You Need to Know The news comes like a sledgehammer into the stomach: "I'm sorry to tell you, but you have cancer." Every year, a million Americans are devastated by news of can...learn more >>

Patient Comments & Reviews

The eMedicineHealth doctors ask about Myeloma:

Myeloma - Treatment

What was the treatment for your myeloma?

Myeloma - Prevention and Outlook

What prevention measures do you use to avoid getting myeloma?

Myeloma - Experience

Please describe your experience with myeloma.

Multiple Myeloma - Symptoms

The symptoms of multiple myeloma can vary greatly from patient to patient. What were your symptoms at the onset of your disease?

Read What Your Physician is Reading on Medscape

Myeloma »

Multiple myeloma (MM) is characterized by neoplastic proliferation of plasma cells involving more than 10% of the bone marrow.

Read More on Medscape Reference »

Medical Dictionary